肺泡表面活性物质

fèi pào biǎo miàn huó xìnɡ wù zhì
  • alveolar surfactant
肺泡表面活性物质肺泡表面活性物质
  1. 结果提示:并发于急性出血性胰腺炎的肺损伤以肺泡表面活性物质系统受损为一重要的表现形式。

    The results suggest that the lung injury resulting from acute hemorrhagic pancreatitis was characterized by alveolar surfactant System damage .

  2. 肺泡表面活性物质(PS)对盐酸吸入性肺损伤的治疗进展

    Progress of Pulmonary Surfactant in Treatment of the Second Phase ALI / ARDS Induced by Hydrochloric Acid Inhalation

  3. 目的评价外源性肺泡表面活性物质(PS)治疗婴儿体外循环后肺损伤的疗效。

    Objective To evaluate the effect of exogenous pulmonary surfactant ( PS ) replacement therapy for infants who suffered pulmonary injury after cardiopulmonary bypass .

  4. 目的研究患急性呼吸窘迫综合征(ARDS)时病人肺泡表面活性物质的变化。

    Objective To study the changes of pulmonary surfactant in patients with acute respiratory distress syndrome ( ARDS ) .

  5. 目的探讨氧化应激对肺泡表面活性物质结合蛋白A(SPA)表达的调控作用。

    Objective To investigate the transcriptional regulation of oxidative stress on the expression of surfactant protein A ( SPA ) .

  6. 目的研究开胸手术致术侧肺损伤引起肺泡表面活性物质(PS)下降,及盐酸氨溴索(ambroxol)对此的保护作用。

    Purpose To investigate whether thoracotomy can induce lung injury in the operative side and the protection by ambroxol in this procedure .

  7. 表面活性物质B(surfactantproteinB,SP-B)是肺泡表面活性物质的基本成分,起着减小肺泡表面张力的作用,对于出生后呼吸适应是必需的。

    Surfactant protein B ( SP-B ) is an essential component of surfactant . It plays a role of diminishing alveolar surface tension , and is required for postnatal respiratory adaptation .

  8. 结果:①冷暴露各组肺泡表面活性物质(PS)明显高于对照组(P0.001),支气管肺泡灌洗液内细胞总数C1D组明显低于对照组(P0.05),C2W组明显高于对照组(P0.05)。

    The results were as follows . ( 1 ) . The pulmonary surfactant of cold exposure groups was higher than that of control group ( P0.001 ) .

  9. 目的:研究牛肺泡表面活性物质(BPS)替代治疗肺灌洗大鼠时的量效关系。

    Objective : To evaluate the dose response relationship of bovine surfactant ( BPS ) replacement therapy in rat ARDS models .

  10. 肺泡表面活性物质(PS)在维持正常的肺功能起着重要作用,业已证明,PS异常与ALI/ARDS的发病有关,给予外源性PS亦可治疗ALI/ARDS。

    It has been attested that PS alterations have been implicated in the pathophysiology of ALI / ARDS , and that exogenous PS can exert therapeutic effect on patients with ALI / ARDS .

  11. 肺水肿、肺萎陷以及换气功能障碍与肺泡表面活性物质(Pulmonarysurfactant,PS)减少有着密切关系。

    Pneumonedema , alveolar and dysfunction of gas exchange is closely related to the decrease of pulmonary surfactant ( PS ) . Pulmonary hemorrhage and pneumonedema are the significant pathological traits of pulmonary injury in blast injury .

  12. 目的探讨气管注入肺泡表面活性物质(PS)对大鼠呼吸机相关性肺损伤(VILI)的保护作用及机制。

    Objective To observe the effects of exogenous pulmonary surfactant ( PS ) on ventilation-induced lung injury ( VILI ) in rats , and to investigate its possible mechanisms .

  13. 本文报道42例经X线检查和/或病理证实的RDS,引起RDS机理系肺泡表面活性物质缺乏迄今仍认为是主要因素。

    This article is dealt with 42 cases of RDS , which was confirmed both radiographically and pathologically . The machanism responsible for RDS is lack of the surfactant , which is considered a main factor up to the present .

  14. 肺泡表面活性物质主要活性成份磷脂酰胆碱、磷脂酰甘油和二磷脂酰甘油的百分比在ARDS早期升高,分别达562%±28%、92%±15%和29%±07%。

    The percentages of three mian active components of pulmonary surfactant were markedly higher during early ARDS . Phosphatidylcholine , phosphatidylglycerol and diphosphatidylglycerol reached to 56 0 % ± 2 8 % , 9 2 % ± 1 5 % and 2 9 % ± 0 7 % respectively .

  15. 外源性肺泡表面活性物质在婴儿心脏直视术后的应用

    Administration of exogenous pulmonary surfactant after cardiac surgery in infants

  16. 内毒素血症大鼠血浆对肺泡表面活性物质功能的抑制及其机理

    Inhibition of Pulmonary Surfactant Function by Endotoxic Rat Plasma and Its Mechanisms

  17. 大鼠烫伤后肺泡表面活性物质系统的变化

    Changes of pulmonary surfactant system in rats after thermal injury

  18. 烟雾吸入性肺损伤肺泡表面活性物质结合蛋白A表达异常机制的研究

    Study on the mechanisms of abnormal spa expression after smoke inhalation injury

  19. 缺氧对家兔肺泡表面活性物质中各磷脂组分的影响

    Effect of hypoxia on components of phospholipids in pulmonary surfactant of rabbits

  20. 淡水溺水后犬肺泡表面活性物质的变化

    Changes of lung surfactant in dogs after fresh water drowning

  21. 大鼠冷暴露后肺泡表面活性物质及血中红白细胞计数的变化

    Changes of Rat Pulmonary Surfactant and Blood Cell Count after Cold Exposure

  22. 哮喘豚鼠肺泡表面活性物质分泌的实验研究

    Experimental Study of Pulmonary Surfactant Secretion in Asthmatic Guinea Pigs

  23. 羊水肺泡表面活性物质和呼气末正压通气治疗呼吸窘迫综合征的实验研究

    Experimental Study of Pulmonary Surfactant Replacement Therapy and PEEP for the Respiratory Distress Syndrome

  24. 肺泡表面活性物质在吸入性全身麻醉中防御功能的研究进展

    Defensive function of pulmonary surfactants in inhalant anesthesia

  25. 不同方式注入肺泡表面活性物质的疗效观察

    Study of the therapeutic effect of intratracheal injection of pulmonary surfactant with different method

  26. 肺泡表面活性物质与大鼠冲击伤-缺氧复合伤早期肺损伤

    The Relationship between Pulmonary Surfactant and Early-phase Pulmonary Injury in Combined Blast-anoxic Injury in Rat

  27. 肺泡表面活性物质对糖尿病大鼠经肺喷入的胰岛素吸收的影响

    The experimental observation of the pulmonary insulin Absorption enhanced by pulmonary surfactants in diabetic rats

  28. 肺泡表面活性物质在金黄地鼠实验性慢性阻塞性肺病中的防治作用

    Protective and Therapeutic Effect of Pulmonary Surfactant on the Experimental Chronic Obstructive Pulmonary Disease in Hamsters

  29. 肺泡表面活性物质对豚鼠迷走神经性肺损伤的治疗作用

    The effect of pulmonary surfactant replacement on acute lung injury induced by bilateral cervical vagotomy in guinea pigs

  30. 红芪对油酸型肺损伤大鼠肺泡表面活性物质含量及板层小体的影响

    Effects of Radix Hedysari on Changes of Pulmonary Surfactant and Osmiophilic Multilamellar Body in Rats with Respiratory Distress Syndrome